Virginia Retirement Systems’s Amphastar Pharmaceuticals AMPH Stock Holding History

Virginia Retirement Systems’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,362	Closed	-$331K	–	942
2025 Q4	$331K	Sell	12,362 -1,200	-9%	-$30.9K	﹤0.01%	831
2025 Q3	$361K	Buy	13,562 +4,800	+55%	+$124K	﹤0.01%	814
2025 Q2	$201K	Sell	8,762 -800	-8%	-$19.9K	﹤0.01%	902
2025 Q1	$277K	Buy	+9,562	New	+$305K	﹤0.01%	899
2023 Q3	$1.05M	Sell	22,800 -6,500	-22%	-$355K	0.01%	502
2023 Q2	$1.68M	Buy	29,300 +2,400	+9%	+$106K	0.02%	397
2023 Q1	$1.01M	Buy	26,900 +1,300	+5%	+$42.6K	0.01%	546
2022 Q4	$717K	Buy	25,600 +8,900	+53%	+$258K	0.01%	717
2022 Q3	$469K	Buy	+16,700	New	+$545K	0.01%	818

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Virginia Retirement Systems's AMPH Position: Q1 2026 in Review

Virginia Retirement Systems sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 12,362 shares — an estimated $331K sold.

Virginia Retirement Systems first reported a position in AMPH in Q3 2022 and held it in 9 quarters. The position peaked at $1.68M in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Virginia Retirement Systems reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Virginia Retirement Systems sold 12,362 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $331K.
Virginia Retirement Systems first reported a position in Amphastar Pharmaceuticals in Q3 2022 and held it in 9 quarters.
Virginia Retirement Systems's Amphastar Pharmaceuticals position peaked at $1.68M in Q2 2023.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Virginia Retirement Systems's 13F filing for Q1 2026, filed 25 Aug 2026.